Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 17, 2021
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
Fri, May 14, 2021
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
Daniel Busby Initiated (VRCA) at Buy and Held Target at $19 on, May 14th, 2021
Daniel Busby of RBC Capital, Initiated "Verrica Pharmaceuticals Inc." (VRCA) at Buy and Held Target at $19 on, May 14th, 2021.
Daniel has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Daniel's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Daniel
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Monday, March 8th, 2021
- Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $22 on, Wednesday, February 17th, 2021
